Neurotech International Overview
- Year Founded
-
2006
- Status
-
Public
- Employees
-
2
- Stock Symbol
-
NTI
- Share Price
-
$0.01
- (As of Thursday Closing)
Neurotech International General Information
Description
Neurotech International Ltd is a clinical-stage biopharmaceutical development company focused predominantly on paediatric neurological disorders with a broad-spectrum oral cannabinoid drug therapy called NTI164. It has completed a Phase II/III randomised, double-blind, placebo-controlled clinical trial in Autism Spectrum Disorder (ASD) with clinically meaningful and statistically benefits reported across a number of clinically-validated measures and excellent safety. In addition, Neurotech has completed and reported statistically and clinically meaningful Phase I/II trials in ASD and Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) and Paediatric Acute-Onset Neuropsychiatric Syndrome (PANS), along with Rett Syndrome.
Contact Information
Website
www.neurotechinternational.comCorporate Office
- Level 1, 55 Collins Street
- Suite 102
- Melbourne, Victoria 3000
- Australia
Corporate Office
- Level 1, 55 Collins Street
- Suite 102
- Melbourne, Victoria 3000
- Australia
Neurotech International Timeline
Neurotech International Stock Performance
As of 12-Nov-2026, Neurotech International’s stock price is $0.01. Its current market cap is $22.1M with 1.62B shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.01 | $0.01 | $22.1M | 1.62B | 4.48M |
Neurotech International Financials Summary
As of 30-Sep-2026, Neurotech International has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 30-Jun-2026 | FY 2025 30-Jun-2025 | FY 2024 30-Jun-2024 |
|---|---|---|---|---|
| EV | 15,203 | 8,332 | 6,389 | 44,383 |
| Revenue | 1 | 1 | ||
| EBITDA | (4,460) | (6,946) | (3,425) | |
| Net Income | (4,429) | (6,858) | (3,322) | |
| Total Assets | 1,891 | 2,117 | 8,163 | |
| Total Debt | 0 | 0 | 0 |
Neurotech International Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Neurotech International Patents
Neurotech International Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024903747-A0 | Compositions and methods for modifying proteomic pathways | Pending | 14-Nov-2024 | ||
| AU-2024902820-A0 | Compositions and methods for modifying proteomic pathways | Pending | 06-Sep-2024 | ||
| WO-2026050814-A1 | Compositions and methods for modifying proteomic pathways | Pending | 06-Sep-2024 | ||
| AU-2022902914-A0 | Methods for treating paediatric neurological disorders | Pending | 06-Oct-2022 | ||
| AU-2023356549-A1 | Methods for treating paediatric neurological disorders | Pending | 06-Oct-2022 | A61K31/658 |
Neurotech International Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Neurotech International ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Neurotech International FAQs
-
When was Neurotech International founded?
Neurotech International was founded in 2006.
-
Where is Neurotech International headquartered?
Neurotech International is headquartered in Melbourne, Australia.
-
What is the size of Neurotech International?
Neurotech International has 2 total employees.
-
What industry is Neurotech International in?
Neurotech International’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Neurotech International a private or public company?
Neurotech International is a Public company.
-
What is Neurotech International’s stock symbol?
The ticker symbol for Neurotech International is NTI.
-
What is the current stock price of Neurotech International?
As of 12-Nov-2026 the stock price of Neurotech International is $0.01.
-
What is the current market cap of Neurotech International?
The current market capitalization of Neurotech International is $22.1M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
